? We tripled our phase I activity with focus on psychiatry and neurology ? 28% increase in our pain business – migraine, OA and chronic pain ? Psychiatry still core therapeutic area with depression and schizophrenia leading the way in 2011 ? 70% of the total business was with CROs
Read More